Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Decoding the Future of HF — Key Takeaways from 2024
Author(s): Muthiah Vaduganathan , Orly Vardeny , Added: 1 year ago
Recorded at American Heart Association 2024 in Chicago, Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, Boston, US), Dr Orly Vardeny (University of Minnesota Medical School, Minneapolis, US) and Prof Pardeep Jhund (University of Glasgow, Glasgow, UK) explore cardiometabolic disease in heart failure with mid-range or preserved ejection fraction (HFmrEF and HFpEF)… View more

Heart Failure
3 Trials That Will Change My Practice
Author(s): Muthiah Vaduganathan Added: 1 year ago
ESC 2024 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US) for a concise and insightful summary of the hot-line and late-breaking data that is expected to have an impact on heart failure care.Trials covered in detail include:FINEARTS HFHELIOS-BRESHAPE-HF2Recorded on-site at ESC Congress 2024, London.Editors: Jordan Rance and Mirjam Boros… View more

Heart Failure
Added: 11 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Nandan S Anavekar
Research Area(s) / Expertise:

Imaging & Diagnostics

Congenital Heart Disease

 Job title: Consultant Cardiologist & Professor of Medicine
Dr Nandan S Anavekar, MB, BCh, is Professor of Medicine at Mayo Clinic College of Medicine and Science, where he serves as a consultant in both the Cardiovascular and Radiology Departments. As the Program Director of the Adult Cardiovascular Diseases Fellowship program, he is dedicated to postgraduate education and the advancement of the field. Dr Anavekar is a board-certified expert in… View more
Recognising Undiagnosed Heart Failure in Women
Author(s): Renate B Schnabel , Eva Gerdts , Added: 9 months ago
Cardiovascular disease in women is frequently underdiagnosed, with heart failure often overlooked due to subtle symptoms and persistent clinical bias. In this on-demand symposium, leading experts explore why cardiovascular disease is missed in women, the unique risks and presentations of female heart failure and how early detection of atrial fibrillation can improve outcomes. Chaired by Prof… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial
Author(s): Harriette Van Spall , Stephen Nicholls Added: 7 months ago
AHA Scientific Sessions 2025 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Stephen Nicholls (Monash University, AU) to present the findings of this AHA late-breaking trial.This pre-specified analysis of the SURPASS-CVOT randomised clinical trial evaluates the comparative effects of once-weekly tirzepatide versus dulaglutide on heart failure outcomes in… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Beyond Diuretics: Splanchnic Modulation & Congestion Phenotypes in HF
Author(s): Marat Fudim Added: 3 weeks ago
Dr Marat Fudim (Duke University School of Medicine, Durham, NC, US) joins us to discuss congestion phenotypes in heart failure, the distinction between true volume overload and maladaptive volume redistribution, and the emerging role of greater splanchnic nerve modulation.In this interview, Dr Fudim explores one of the most clinically nuanced challenges in heart failure management:… View more

Heart Failure
Job title: Associate Director of Medical and Scientific Affairs
3 Trials That Will Change My Practice with Dr Deepak Bhatt
Author(s): Deepak L Bhatt Added: 2 months ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO… View more

Intervention

Anticoagulation
Coronary Revascularisation in HFrEF
Author(s): Bernhard Haring , Michael Böhm Added: 2 years ago

Prevention & Chronic Conditions

Heart Failure